Featured Posts
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> 1. BUSINESS Boeing expects to…
Newsletter
The Competitive Enterprise Institute Daily Update
1. HEALTH The West Nile virus makes a comeback in the Midwest. CEI Expert Available to Comment: Director of Risk & Environmental…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. TECHNOLOGY Blue Origin, the private space travel company started by Amazon.com founder Jeff Bezos,…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. REGULATION President Bush urges adoption of the line item veto as a…
Op-Eds
Protection Against Unanticipated Lawsuits
On Monday, in Arlington Central School District v. Murphy, the Supreme Court limited the court costs recoverable under the Individuals with Disabilities Education Act…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. FINANCE The Senate Finance Committee considers the nomination of Goldman Sachs chairman Henry Paulson…